ImmunityBio, Inc. IBRX Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s change in other assets?
- ImmunityBio, Inc. (IBRX) reported change in other assets of $1.05M in Q1 2026.
- How has ImmunityBio, Inc.'s change in other assets changed year-over-year?
- ImmunityBio, Inc.'s change in other assets increased by 1152.4% year-over-year, from $84K to $1.05M.
- What is the long-term trend for ImmunityBio, Inc.'s change in other assets?
- Over 2 years (2022 to 2024), ImmunityBio, Inc.'s change in other assets has grown at a -28.0% compound annual growth rate (CAGR), from -$2.14M to $1.11M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.